Fox Run Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,022
Closed -$559K 1208
2024
Q4
$559K Sell
23,022
-1,570
-6% -$44.8K 0.1% 397
2024
Q3
$914K Buy
24,592
+16,791
+215% +$626K 0.2% 157
2024
Q2
$371K Buy
+7,801
New +$342K 0.07% 503
2023
Q3
Sell
-3,821
Closed -$201K 983
2023
Q2
$201K Buy
+3,821
New +$233K 0.06% 582
2023
Q1
Sell
-14,132
Closed -$686K 916
2022
Q4
$686K Buy
14,132
+8,047
+132% +$505K 0.28% 76
2022
Q3
$429K Buy
6,085
+409
+7% +$35K 0.17% 232
2022
Q2
$403K Buy
+5,676
New +$366K 0.2% 196

Other funds holding STAA

Fox Run Management's STAA Position: Q1 2025 in Review

Fox Run Management sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 23,022 shares — an estimated $559K sold.

Fox Run Management first reported a position in STAA in Q2 2022 and held it in 7 quarters. The position peaked at $914K in Q3 2024. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Fox Run Management reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Fox Run Management sold 23,022 STAAR Surgical shares in Q1 2025, an estimated $559K.
  • Fox Run Management first reported a position in STAAR Surgical in Q2 2022 and held it in 7 quarters.
  • Fox Run Management's STAAR Surgical position peaked at $914K in Q3 2024.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Fox Run Management's 13F filing for Q1 2025, filed 13 May 2025.